Small bowel bacterial overgrowth, celiac disease, and IBS: What are the real associations?

American Journal of Gastroenterology

Volumn 98, Issue 4, 2003, Pages 720-722

  O'Leary, Clare ^a   Quigley, Eamonn M M ^a  

^a University College Cork and INFANT Centre   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

LACTULOSE; RIFAXIMIN;

ABDOMINAL PAIN; ANTIBODY TITER; BACTERIAL COLONIZATION; BACTERIAL GROWTH; BACTERIUM CULTURE; CELIAC DISEASE; CLINICAL FEATURE; DIARRHEA; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE PREDISPOSITION; EDITORIAL; ENTERITIS; GLUTEN FREE DIET; HIGH RISK POPULATION; HUMAN; HYDROGEN BREATH TEST; INTESTINE MOTILITY; PREVALENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PSYCHOLOGICAL ASPECT; RELIABILITY; RISK ASSESSMENT; SCREENING TEST; SEROLOGY; SMALL BOWEL BACTERIAL OVERGROWTH; SMALL INTESTINE DISEASE; STOMACH EMPTYING;

EID: 0037617449     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1572-0241.2003.07395.x     Document Type: Editorial

References (15)

1. Sanders DS, Carter MJ, Hurlstone DP, et al. Association of adult celiac disease with irritable bowel syndrome: A case control study in patients fulfilling Rome II criteria referred to secondary care. Lancet 2001;358:1504-8.
2. Wahnschaffe U, Ullrich R, Riecken O, et al. Celiac disease-like abnormalities in a subgroup of patients with irritable bowel syndrome. Gastroenterology 2001;121:1329-38.
3. O'Leary C, Wieneke P, Buckley S, et al. Celiac disease and irritable bowel-type symptoms. Am J Gastroenterol 2002;97: 1463-7.
4. Fasano A, Catassi C. Current approaches to diagnosis and treatment of celiac disease: An evolving spectrum. Gastroenterology 2001;120:636-51.
5. Neal KR, Hebden J, Spiller R. Prevalence of gastrointestinal symptoms six months after bacterial gastroenteritis and risk factors for development of the irritable bowel syndrome: Postal survey of patients. BMJ 1997;314:779-82.
6. Simrén M, Axelsson J, Gillberg R, et al. Quality of life in inflammatory bowel disease in remission: The impact of IBS-like symptoms and associated psychological factors. Am J Gastroenterol 2002;97:389-96.
7. Gwee KA, Leong YL, Graham C, et al. The role of psychological and biological factors in post-infective gut dysfunction. Gut 1999;44:400-6.
8. Pimental M, Chow E, Lin H. Eradication of small intestinal bacterial overgrowth reduces symptoms of irritable bowel syndrome. Am J Gastroenterol 2000;95:3503-6.
9. Tursi A, Brandimarte G, Giorgetti GM. High prevalence of small intestinal bacterial overgrowth in celiac patients with persistence of gastrointestinal symptoms after gluten withdrawal. Am J Gastroenterol 2003;98:839-43.
10. Riordan S, McIver C, Walker B, et al. The lactulose breath hydrogen test and small intestinal bacterial overgrowth. Am J Gastroenterol 1996;9:1795-803.
11. Corazza G, Menozzi M, Strocchi L, et al. The diagnosis of small bowel bacterial overgrowth. Gastroenterology 1990;98:362-9.
12. Bassotti G, Castellucci G, Betti C, et al. Abnormal gastrointestinal motility in patients with celiac sprue. Dig Dis Sci 1994;39:1947-54.
13. Rostami K, Kerckhaert J, Tiemessen R, Von Blomberg M. Sensitivity of antiendomysium and antigliadin antibodies: Disappointing in clinical practice. Am J Gastroenterol 1999;94: 888-94.
14. Dickey W, Hughes D, McMillan S. Disappearance of endomysial antibodies in treated celiac disease does not indicate histological recovery. Am J Gastroenterol 2000;95: 712-4.
15. Grefte J, Bouman J, Grond J, et al. Slow and incomplete histological and functional recovery in adult gluten sensitive enteropathy. J Clin Pathol 1988;41:886-91.